How many insider declarations does Corbus Pharmaceuticals Holdings, Inc. have?

Corbus Pharmaceuticals Holdings, Inc. has filed 5 insider declarations with SEC (Form 4).

Who is the top reporting insider at Corbus Pharmaceuticals Holdings, Inc.?

The top reporting insider at Corbus Pharmaceuticals Holdings, Inc. is Cohen Yuval, based on the count of public filings.

What is the net insider buy vs sell volume on Corbus Pharmaceuticals Holdings, Inc.?

Across the available history, declared buys total 17k€ and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

Corbus Pharmaceuticals Holdings, Inc.: directors' dealings · United States · SEC (Form 4)

SEC:corbus-pharmaceuticals-holdings-inc-5f1beaUS·SEC (Form 4)

AMF ↗

Explore the full insider trade history of Corbus Pharmaceuticals Holdings, Inc., a listed equity based in United States. Shares trade on US US, under the authority of SEC (Form 4). The latest transaction was reported on 16 May 2022 (Acquisition). Among the most active insiders: Cohen Yuval. All data is free.

5

Insider Decl.

0

Thresholds

€17,236

5 ops.

Buy Volume

·

0 ops.

Sell Volume

Financial data

9.67 €

Analyst consensus

·

Valuation

P/Book1.2x

Balance sheet & cash

Debt / Equity1%

Profitability & ownership

ROE-66.7%

ROA-39.5%

% insiders0.6%

% institutions71.9%

Last declaration on 16 May 2022

All Executives5 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations